Genetic Analysis of Disorders of Fibrosis

Overview

About this study

The specific aim of this protocol is to identify microRNAs that are differentially expressed between diseased fibrotic tissue (dupuytrens disease and plantar fibromatosis) and normal fibrotic tissue.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  • Patients greater than age 18 undergoing a surgical procedure where fibrous tissue can be collected as surgical waste tissue

Exclusion Criteria: 

  • Patients who are younger than age 18 
  • Patients who are pregnant

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sanjeev Kakar, M.D.

Contact us for the latest status

Contact information:

Sanjeev Kakar M.D.

(507) 284-4828

Kakar.Sanjeev@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20313272

Mayo Clinic Footer